Publication | Closed Access

Perioperative inhibition of β-adrenergic and COX2 signaling in a clinical trial in breast cancer patients improves tumor Ki-67 expression, serum cytokine levels, and PBMCs transcriptome

Breast OncologyBreast Cancer PatientsMedicinePharmacologyBreast CancerTumor Ki-67 ExpressionCancer TreatmentOncologyCell BiologyPbmcs TranscriptomeEndocrine-related Cancer